HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Suppression of arthritis by an active center analogue of Cu2Zn2-superoxide dismutase.

Abstract
The anti-arthritic and anti-inflammatory efficacy of CuPu(Py)2 ([N,N'-bis(2-pyridylmethylene)-1,4-butanediamine] (N,N',N",N"))-Cu(II), a serum-stable active center analogue of Cu2Zn2-superoxide dismutase (SOD; EC 1.15.1.1), was tested in male DBA/1 x B10A (4R) mice suffering from potassium-peroxochromate-induced (PIA) or collagen type II-induced arthritis (CIA). Parameters including the arthritis index, the plasma SOD activity, and the inhibition of phagocytic responses in unseparated blood were used for the assessment of disease activity. A dose-dependent suppression of arthritis was noted in both models. The ED50 was 2.5 +/- 0.4 mumol/kg/day of CuPu(Py)2 for PIA and 4.0 +/- 1.1 mumol/kg/day for CIA. The arthritis index correlated with both the levels of reactive oxygen species (ROS) generated by phorbol ester-activated neutrophils and monocytes in unseparated blood (r = 0.892) and the SOD-like activity in plasma (r = 0.857). CuPu(Py)2 inhibited also the lipoplysaccharide-induced release of tumor necrosis factor alpha from human monocytes and neutrophils in a dose-dependent manner. Unlike SOD, which exerts successful anti-rheumatic activity mainly upon intra-articular injection, the SOD-mimic CuPu(Py)2 can be applied systemically. Non-proteinaceous low molecular weight antioxidases may well be suited to control oxidative stress-derived damage in rheumatic diseases by modulation of ROS-dependent signal transduction pathways.
AuthorsR Miesel, A Dietrich, B Brandl, N Ulbrich, M Kurpisz, H Kröger
JournalRheumatology international (Rheumatol Int) Vol. 14 Issue 3 Pg. 119-26 ( 1994) ISSN: 0172-8172 [Print] Germany
PMID7839072 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Chromates
  • Organometallic Compounds
  • Peroxides
  • Schiff Bases
  • Tumor Necrosis Factor-alpha
  • potassium tetraperoxochromate
  • Collagen
  • N,N'-bis(2-pyridylmethylene)-1,4-butanediamine (N,N',N'',N''')-Cu(II)diperchlorate
  • Superoxide Dismutase
Topics
  • Animals
  • Arthritis (blood, chemically induced, drug therapy, enzymology)
  • Chromates (pharmacology)
  • Collagen (pharmacology)
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Luminescent Measurements
  • Male
  • Mice
  • Mice, Inbred DBA
  • Organometallic Compounds (pharmacology, therapeutic use)
  • Peroxides (pharmacology)
  • Schiff Bases (pharmacology, therapeutic use)
  • Superoxide Dismutase (biosynthesis, blood, drug effects)
  • Tumor Necrosis Factor-alpha (biosynthesis, drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: